STERIS plc
NYSE:STE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
199.01
247.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
STERIS plc
STERIS plc
Cash from Operating Activities
STERIS plc
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
STERIS plc
NYSE:STE
|
Cash from Operating Activities
$1.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
17%
|
|
|
Medtronic PLC
NYSE:MDT
|
Cash from Operating Activities
$7.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Cash from Operating Activities
-$7.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
STERIS plc
Glance View
Emerging as a silent pioneer in the intricate world of sterilization and infection prevention, STERIS plc has carved out a significant niche in the healthcare industry. Originally founded in 1985, the company has grown through strategic acquisitions and organic expansion. It primarily focuses on protecting patients by ensuring high standards of cleanliness and safety in healthcare environments. STERIS offers a broad array of products and services, from sophisticated sterilization equipment for hospital operating rooms to surface disinfectants and washes that keep healthcare facilities safe and clean. Their diverse portfolio ensures that they can meet the evolving needs of the global healthcare sector, which increasingly demands stringent infection control protocols. What sets STERIS apart is its innovative approach to both service and product offerings, which blend together to create comprehensive infection prevention solutions. By marrying state-of-the-art technology with a service-oriented business model, the company supports hospitals, medical-device companies, and research labs by maintaining their operational readiness and compliance with health standards. Revenue is generated through a mix of product sales as well as renewable service contracts, which guarantee recurring income. These long-term service agreements, alongside the consistent demand for advanced sterilization solutions, have enabled STERIS to sustain and even enhance its financial health while supporting the mission of safer patient care globally.
See Also
What is STERIS plc's Cash from Operating Activities?
Cash from Operating Activities
1.1B
USD
Based on the financial report for Sep 30, 2024, STERIS plc's Cash from Operating Activities amounts to 1.1B USD.
What is STERIS plc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
17%
Over the last year, the Cash from Operating Activities growth was 30%. The average annual Cash from Operating Activities growth rates for STERIS plc have been 18% over the past three years , 14% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
